Results

Ocugen Inc.

04/19/2024 | Press release | Distributed by Public on 04/19/2024 05:19

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy